Canopy Growth Corp

CGC Biotech & pharma

Produces cannabis products for medical and adult-use purposes.

Jun 2026Revenue C$294M/yrExpenses C$455M/yr
No trendCash runway ≈ 4.0 years from Jun 2026
Figures by year

When will Canopy Growth be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was C$294M and expenses C$455M.

Fiscal year toRevenueExpensesOperating profit
Mar 2026C$285MC$446M−C$162M
Mar 2025C$269MC$386M−C$117M
Mar 2024C$297MC$526M−C$229M
Mar 2023C$333MC$2.96B−C$2.63B
Mar 2022C$476MC$1.49B−C$1.02B
Mar 2021C$547MC$1.79B−C$1.24B
Mar 2020C$399MC$2.07B−C$1.67B
Mar 2019C$226MC$864M−C$637M
Mar 2018C$77.9MC$198M−C$120M